Agios Pharmaceuticals, Inc. (AGIO)
34.04
+2.72
(+8.68%)
USD |
NASDAQ |
Oct 19, 13:55
Agios Pharmaceuticals Cash from Operations (Annual) : -372.98M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -372.98M |
| December 31, 2024 | -389.84M |
| December 31, 2023 | -296.06M |
| December 31, 2022 | -309.48M |
| December 31, 2021 | -407.32M |
| December 31, 2020 | -290.76M |
| December 31, 2019 | -370.62M |
| December 31, 2018 | -304.42M |
| Date | Value |
|---|---|
| December 31, 2017 | -285.23M |
| December 31, 2016 | 38.56M |
| December 31, 2015 | -76.95M |
| December 31, 2014 | -59.35M |
| December 31, 2013 | -56.40M |
| December 31, 2012 | -49.55M |
| December 31, 2011 | -15.22M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 109.84M |
| Biogen, Inc. | 2.205B |
| Insmed, Inc. | -935.01M |
| Alnylam Pharmaceuticals, Inc. | 524.08M |
| Regeneron Pharmaceuticals, Inc. | 4.979B |